Rifampicin-induced nephrotoxicity in a tuberculosis patient
| Autor: | Naveen Patil, Alexandria Beebe, Barbara Seaworth |
|---|---|
| Rok vydání: | 2015 |
| Předmět: |
Microbiology (medical)
Pulmonary and Respiratory Medicine Renal failure medicine.medical_specialty Tuberculosis Renal function urologic and male genital diseases Article lcsh:Infectious and parasitic diseases Nephrotoxicity Mycobacterium tuberculosis Internal medicine Medicine lcsh:RC109-216 AIN Intensive care medicine Adverse effect Rifampicin lcsh:RC705-779 biology business.industry lcsh:Diseases of the respiratory system medicine.disease biology.organism_classification Discontinuation Infectious Diseases Toxicity business medicine.drug |
| Zdroj: | Journal of Clinical Tuberculosis and Other Mycobacterial Diseases, Vol 1, Iss, Pp 13-15 (2015) Journal of Clinical Tuberculosis and Other Mycobacterial Diseases |
| ISSN: | 2405-5794 |
| DOI: | 10.1016/j.jctube.2015.09.001 |
| Popis: | Rifampicin is a widely used anti-tuberculosis agent. On rare occasions, the drug can cause adverse effects such as acute renal failure, though most regain complete renal function upon discontinuation of therapy. The following case report describes a 38 year old Hispanic male presenting with pulmonary tuberculosis who developed rifampicin-induced renal toxicity. He recovered renal function upon discontinuation of the medication without the use of corticosteroids. Keywords: Mycobacterium tuberculosis, Rifampicin, Renal failure, AIN |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|